These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25827545)

  • 21. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review.
    Smith SJ; Smith BD; Mohney BG
    Br J Ophthalmol; 2014 Mar; 98(3):292-7. PubMed ID: 24187047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S; Balcı Ö; Tanyıldız B; Kebudi R; Shields CL
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.
    Kaczmarek JV; Bogan CM; Pierce JM; Tao YK; Chen SC; Liu Q; Liu X; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Friedman DL; Richmond A; Daniels AB
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):8. PubMed ID: 34757417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
    Lawson BM; Saktanasate J; Say EA; Shields CL
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy.
    Raval V; Bowen RC; Soto H; Singh A
    Asia Pac J Ophthalmol (Phila); 2020 Sep; 10(2):200-202. PubMed ID: 32925294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity.
    Seregard S; Singh AD
    Br J Ophthalmol; 2012 Apr; 96(4):473-4. PubMed ID: 22421997
    [No Abstract]   [Full Text] [Related]  

  • 28. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
    Shields CL; Lally SE; Leahey AM; Jabbour PM; Caywood EH; Schwendeman R; Shields JA
    Curr Opin Ophthalmol; 2014 Sep; 25(5):374-85. PubMed ID: 25014750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature.
    Lavasidis G; Strongylis M; Tzamalis A; Tsinopoulos I; Ntzani EE
    Crit Rev Oncol Hematol; 2024 Aug; 200():104423. PubMed ID: 38897313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
    Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
    Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of retinoblastoma RNA reflux after intravitreal injection of melphalan.
    Winter U; Nicolas M; Sgroi M; Sampor C; Torbidoni A; Fandiño A; Chantada GL; Munier FL; Schaiquevich P
    Br J Ophthalmol; 2018 Mar; 102(3):415-418. PubMed ID: 29089355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds.
    Goldsmith ZK; Coppess W; Irvine AS; Yuan K; Barsh SR; Ritter MK; McEwen MW; Flores-Otero J; Garcia-Vargas A; Martinez-Ferrer M; Brennan RC; Morales-Tirado VM; Wilson MW
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4486-4495. PubMed ID: 30193324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.